Charles River Laboratories International Aktie
| 169,77USD | 5,41USD | 3,29% |
WKN: 939391 / ISIN: US1598641074
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 20 000 | 21 400 | 21 800 | 20 100 | 19 700 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,18 | 0,19 | 0,19 | 0,20 | 0,20 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1 274 | 1 439 | 1 609 | 1 403 | 1 447 |
| Summe Anlagevermögen | 5 750 | 6 164 | 6 586 | 6 125 | 5 688 |
| Summe Aktiva | 7 024 | 7 603 | 8 195 | 7 528 | 7 135 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 4 432 | 4 579 | 4 536 | 4 020 | 3 924 |
| Summe Eigenkapital | 2 592 | 3 024 | 3 659 | 3 508 | 3 211 |
| Summe Passiva | 7 024 | 7 603 | 8 195 | 7 528 | 7 135 |
Adresse
| 251 Ballardvale Street, 01887 Wilmington | |
| Telefon | +1 (781) 222-6000 |
| Internet | http://www.criver.com |
Management
|
Abraham N. Ceesay
Independent Director |
|
Birgit Girshick
Chief Operating Officer & Executive Vice President |
|
Brian Bathgate
Senior Vice President-European Safety Assessment |
|
Colin Dunn
Senior VP, GM-Research Models & Services |
|
Craig B. Thompson
Independent Director |
|
Foster T. Jordan
Senior Vice President-Microbial Solutions |
|
George Llado
Independent Director |
|
Gina M. Mullane
Chief Marketing Officer & Senior Vice President |
|
James C. Foster
Chairman, President & Chief Executive Officer |
|
John C. Ho
Chief Strategy Officer & SVP-Corporate Strategy |
|
Joseph W. LaPlume
Executive VP-Corporate Development & Strategy |
|
Julie Frearson
Chief Scientific Officer & Senior Vice President |
|
Kristen M. Eisenhauer
Chief Commercial Officer & Senior Vice President |
|
Mark Joseph Enyedy
Independent Director |
|
Mark Mintz
Chief Information Officer & Senior Vice President |
|
Martin W. MacKay
Lead Independent Director |
|
Matthew L. Daniel
Secretary, Chief Compliance Officer & Senior VP |
|
Michael Gunnar Knell
SVP, Chief Financial & Accounting Officer |
|
Namandje N. Bumpus
Senior VP, Chief Innovation & Scientific Officer |
|
Nancy C. Andrews
Independent Director |
|
Paul W. Graves
Independent Director |
|
Reshema Kemps-Polanco
Independent Director |
|
Shannon M. Parisotto
Executive VP-Global Discovery & Safety Assessment |
|
Steven Barg
Independent Director |
|
Todd Spencer
Vice President-Investor Relations |
|
Victoria L. Creamer
Chief People Officer & Executive Vice President |
|
Virginia M. Wilson
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.